|
PTPN9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.780500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.253800E-02 |
| Normal-vs-Stage2 |
1.239870E-03 |
| Normal-vs-Stage3 |
3.790600E-01 |
| Normal-vs-Stage4 |
6.189300E-04 |
| Stage1-vs-Stage2 |
2.167600E-01 |
| Stage1-vs-Stage3 |
6.627800E-01 |
| Stage1-vs-Stage4 |
1.104210E-01 |
| Stage2-vs-Stage3 |
2.051000E-01 |
| Stage2-vs-Stage4 |
5.007800E-01 |
| Stage3-vs-Stage4 |
1.910360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.000240E-02 |
| Normal-vs-AfricanAmerican |
1.102990E-01 |
| Normal-vs-Asian |
4.758800E-03 |
| Caucasian-vs-AfricanAmerican |
8.606800E-01 |
| Caucasian-vs-Asian |
3.776200E-01 |
| AfricanAmerican-vs-Asian |
3.722200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.646500E-04 |
| Normal-vs-Female |
8.492600E-01 |
| Male-vs-Female |
7.919800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.821820E-01 |
| Normal-vs-Extreme_Weight |
1.141300E-03 |
| Normal-vs-Obese |
5.342400E-01 |
| Normal-vs-Extreme_Obese |
1.350020E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.375200E-01 |
| Normal_Weight-vs-Obese |
4.937600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.014500E-02 |
| Extreme_Weight-vs-Obese |
5.357800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.824400E-01 |
| Obese-vs-Extreme_Obese |
1.046420E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.803000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.459400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.155500E-04 |
| Normal-vs-Age(81-100Yrs) |
3.199600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.861400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.464400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.605830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.634200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.708490E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.981000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.475700E-02 |
| Normal-VS-Type2 PRCC |
2.400500E-03 |
| Normal-VS-KIRP CIMP |
1.980200E-01 |
| Normal-VS-Unclassified PRCC |
3.647000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.822400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.962600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.394800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.259000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.429200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.858000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.15800000002986E-06 |
| Normal-vs-N1 |
3.524400E-01 |
| Normal-vs-N2 |
4.384000E-02 |
| N0-vs-N1 |
1.477510E-02 |
| N0-vs-N2 |
7.426800E-01 |
| N1-vs-N2 |
4.308000E-01 |
|
|
